Home/Filings/4/0001082504-06-000003

4//SEC Filing

BLUMBERG CAPITAL MANAGEMENT LLC 4

Accession 0001082504-06-000003

CIK 0000913443other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 6:01 PM ET

Size

31.2 KB

Accession

0001082504-06-000003

Insider Transaction Report

Form 4

Period: 2006-01-04

CAMBRIDGE HEART INCCAMH

BLUMBERG CAPITAL ADVISORS LLC

10% Owner

Transactions

Conversion
Common Stock
2006-01-04+31,590→ 94,770 total(indirect: See Notes)
Conversion
Warrants
2006-01-04−233,064→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (233,064 underlying)
Conversion
Warrants
2006-01-04−31,590→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (31,590 underlying)
Conversion
Common Stock
2006-01-04+233,064→ 699,192 total(indirect: See Notes)

Holdings

Warrants
(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (882,336 underlying)
882,336
Common Stock
(indirect: See Notes)
1,782,672
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (1,176,461 underlying)
1,176,461
Common Stock
(indirect: See Notes)
316,500
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (310,778 underlying)
310,778
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (42,159 underlying)
42,159

AFB FUND LLC

10% Owner

Transactions

Conversion
Common Stock
2006-01-04+233,064→ 699,192 total(indirect: See Notes)
Conversion
Warrants
2006-01-04−233,064→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (233,064 underlying)
Conversion
Common Stock
2006-01-04+31,590→ 94,770 total(indirect: See Notes)
Conversion
Warrants
2006-01-04−31,590→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (31,590 underlying)

Holdings

Common Stock
(indirect: See Notes)
1,782,672
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (1,176,461 underlying)
1,176,461
Warrants
(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (882,336 underlying)
882,336
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (310,778 underlying)
310,778
Common Stock
(indirect: See Notes)
316,500
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (42,159 underlying)
42,159

BLUMBERG LIFE SCIENCES FUND LTD

10% Owner

Transactions

Conversion
Warrants
2006-01-04−31,590→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (31,590 underlying)
Conversion
Common Stock
2006-01-04+233,064→ 699,192 total(indirect: See Notes)
Conversion
Common Stock
2006-01-04+31,590→ 94,770 total(indirect: See Notes)
Conversion
Warrants
2006-01-04−233,064→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (233,064 underlying)

Holdings

Common Stock
(indirect: See Notes)
316,500
Common Stock
(indirect: See Notes)
1,782,672
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (1,176,461 underlying)
1,176,461
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (42,159 underlying)
42,159
Warrants
(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (882,336 underlying)
882,336
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (310,778 underlying)
310,778

BLUMBERG LOUIS

10% Owner

Transactions

Conversion
Common Stock
2006-01-04+233,064→ 699,192 total(indirect: See Notes)
Conversion
Warrants
2006-01-04−31,590→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (31,590 underlying)
Conversion
Common Stock
2006-01-04+31,590→ 94,770 total(indirect: See Notes)
Conversion
Warrants
2006-01-04−233,064→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (233,064 underlying)

Holdings

Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (42,159 underlying)
42,159
Warrants
(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (882,336 underlying)
882,336
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (310,778 underlying)
310,778
Common Stock
(indirect: See Notes)
316,500
Common Stock
(indirect: See Notes)
1,782,672
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (1,176,461 underlying)
1,176,461

BLUMBERG LIFE SCIENCES FUND LP

10% Owner

Transactions

Conversion
Warrants
2006-01-04−233,064→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (233,064 underlying)
Conversion
Warrants
2006-01-04−31,590→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (31,590 underlying)
Conversion
Common Stock
2006-01-04+233,064→ 699,192 total(indirect: See Notes)
Conversion
Common Stock
2006-01-04+31,590→ 94,770 total(indirect: See Notes)

Holdings

Warrants
(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (882,336 underlying)
882,336
Common Stock
(indirect: See Notes)
316,500
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (310,778 underlying)
310,778
Common Stock
(indirect: See Notes)
1,782,672
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (42,159 underlying)
42,159
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (1,176,461 underlying)
1,176,461

BLUMBERG CAPITAL MANAGEMENT LLC

10% Owner

Transactions

Conversion
Warrants
2006-01-04−31,590→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (31,590 underlying)
Conversion
Common Stock
2006-01-04+31,590→ 94,770 total(indirect: See Notes)
Conversion
Common Stock
2006-01-04+233,064→ 699,192 total(indirect: See Notes)
Conversion
Warrants
2006-01-04−233,064→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (233,064 underlying)

Holdings

Common Stock
(indirect: See Notes)
316,500
Common Stock
(indirect: See Notes)
1,782,672
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (42,159 underlying)
42,159
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (1,176,461 underlying)
1,176,461
Warrants
(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (882,336 underlying)
882,336
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (310,778 underlying)
310,778

BLUMBERG LAURENCE J

10% Owner

Transactions

Conversion
Warrants
2006-01-04−233,064→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (233,064 underlying)
Conversion
Warrants
2006-01-04−31,590→ 0 total(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (31,590 underlying)
Conversion
Common Stock
2006-01-04+233,064→ 699,192 total(indirect: See Notes)
Conversion
Common Stock
2006-01-04+31,590→ 94,770 total(indirect: See Notes)

Holdings

Common Stock
(indirect: See Notes)
1,782,672
Common Stock
(indirect: See Notes)
316,500
Warrants
(indirect: See Notes)
Exercise: $0.42From: 2003-05-12Exp: 2009-01-01→ Common Stock (882,336 underlying)
882,336
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (310,778 underlying)
310,778
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (42,159 underlying)
42,159
Series A Preferred Stock
(indirect: See Notes)
Exercise: $0.34From: 2003-05-12→ Common Stock (1,176,461 underlying)
1,176,461

Footnotes (9)

[F1]Blumberg Life Sciences Fund, L.P. ("BLSF") exercised warrants, exempt for purposes of Section 16(b) of the Securities Exchange Act of 1934 as amended (the "Act") pursuant to Rule 16b-6 of the Act, to purchase 17,928 shares of convertible Series A Preferred Stock at $5.525 per share for an aggregate price of $99,052.20 and thereafter immediately converted such shares, at a conversion ratio of 1:13, into 233,064 shares of Common Stock. The effective exercise price of the warrants for the shares of underlying Common Stock was $0.425 per share.
[F2]Each of the reporting persons and the joint filers (individually, each a "Reporting Person" and collectively, the "Reporting Persons") disclaims beneficial ownership of the reported securities except to the extent of his or its (if any) pecuniary interest therein. The Reporting Persons may be deemed to be a "group" for purposes of Rule 16a-1(a)(1) of the Act and solely for purposes of such Rule are reporting beneficial ownership of the securities held by each of the other Reporting Persons as if beneficially owned by each Reporting Person.
[F3]These securities are held by BLSF. Blumberg Capital Advisors, L.L.C. ("BCA"), the general partner of BLSF, may be deemed to beneficially own these securities by virtue of its position as general partner of BLSF. Blumberg Capital Management, L.L.C. ("BCM") has been delegated investment advisory responsibilities in respect of BLSF by BCA. BCM may be deemed to beneficially own the securities held by BLSF by virtue of BCM's position as investment manager of BLSF. Laurence J. Blumberg is the managing member of both BCM and BCA. By virtue of his position as the managing member of BCM and BCA, Laurence J. Blumberg may be deemed to beneficially own the securities held by BLSF.
[F4]Blumberg Life Sciences Fund, Ltd. ("BLS") exercised warrants, exempt for purposes of Section 16(b) of the Act pursuant to Rule 16b-6 of the Act, to purchase 2,430 shares of convertible Series A Preferred Stock at $5.525 per share for an aggregate price of $13,425.75 and thereafter immediately converted such shares, at a conversion ratio of 1:13, into 31,590 shares of Common Stock. The effective exercise price of the Warrants for the shares of underlying Common Stock was $0.425 per share.
[F5]These securities are held by BLS. BCM is the investment manager of BLS and may be deemed to beneficially own the securities held by BLS by virtue of its position as investment manager of BLS. By virtue of his position as the managing member of BCM, Laurence J. Blumberg may be deemed to beneficially own the securities held by BLS.
[F6]These securities are held by AFB Fund, LLC ("AFB"), a New Jersey limited liability company of which Louis Blumberg is the manager and Laurence J. Blumberg is a member. By virtue of Louis Blumberg's position as the manager of AFB, he may be deemed to beneficially own the securities held by AFB. By virtue of Laurence J. Blumberg's position as a member of AFB, he may be deemed to beneficially own the securities held by AFB.
[F7]These securities are held by Laurence J. Blumberg.
[F8]These securities were previously acquired and reported on the Reporting Persons' Form 3 filed 06/09/2003.
[F9]No expiration date.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

CAMBRIDGE HEART INC

CIK 0000913443

→

Entity typeother

Related Parties

filerCIK 0001241459

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 6:01 PM ET
Size: 31.2 KB

View on SEC.gov